First-line targeted therapy shows antitumor activity in patients with advanced lung cancer

First-line zongertinib showed antitumor activity in treatment-naive patients with advanced or metastatic HER2-mutant ...
The New England Journal of Medicine

Setidegrasib in Advanced Non–Small-Cell Lung Cancer and Pancreatic Cancer

The KRAS p.G12D variant occurs in 5% of patients with non–small-cell lung cancer (NSCLC) and is the most common substitution variant in pancreatic ductal adenocarcinoma, occurring in 40% of patients, ...
ABC7

Rybrevant injections may help Stage 4 lung cancer patients extend their lives

Stage 4 lung cancer used to be a death sentence. Today the survival rate has been steadily on the rise since the 1990s. Now a new targeted treatment that's helping extend the lives of some lung cancer ...
WebMD

Hernexeos: FDA Approves First-Line Use for Certain Advanced Non-Small-Cell Lung Cancers With HER2 Mutations

What Is Hernexeos, and Why Does It Matter? Hernexeos (zongertinib) is a prescription medicine known as a kinase inhibitor that is used for treating adults with advanced non-small-cell lung cancer ...
Reuters

US FDA approves first-line use of Boehringer Ingelheim's lung cancer drug

Feb 26 (Reuters) - The U.S. Food and Drug Administration on Thursday approved Boehringer Ingelheim's zongertinib as a first-line treatment for a rare form of non-small cell lung cancer, making it the ...
ascopubs.org

Therapy for Stage IV Non–Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.0

Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.0 This guideline consolidates all previous updates and reflects the body of evidence informing ...
WBAL-TV

Doctors encourage lung cancer screenings as cases among non-smokers have tripled

PEOPLE WHO NEVER SMOKED OR MINDY BASARA EXPLAINS. YOU KNOW, I HAVE CARROTS. STOP. ISN’T HE HANDSOME? ROBBIE PRESTON LIVES A PEACEFUL LIFE ON A NORTHERN BALTIMORE COUNTY FARM, SURROUNDED BY HER BELOVED ...
ascopubs.org

Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.0

Erratum: Adjuvant Hyperthermic Intraperitoneal Chemotherapy in Patients With Locally Advanced Colon Cancer (COLOPEC): 5-Year Results of a Randomized Multicenter Trial ASCO Guidelines provide ...
Healio

Circulating tumor DNA can help predict survival, relapse for small cell lung cancer

Please provide your email address to receive an email when new articles are posted on . Patients with small cell lung cancer who had higher levels of detectable ctDNA mutations at diagnosis had worse ...
Medical Xpress

Distinct air pollutants show varying links to lung cancer subtypes and survival rates

A recent study has analyzed the relationship between different air pollutants and the main subtypes of lung cancer. The results are published in Environmental Pollution. The work was led by the ...
News Medical

Durvalumab extends survival in small cell lung cancer but raises cost concerns

A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living with small cell lung cancer (SCLC). However, its cost raises questions about ...